| Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern RA Bright, M Medina, X Xu, G Perez-Oronoz, TR Wallis, XM Davis, ... The Lancet 366 (9492), 1175-1181, 2005 | 989 | 2005 |
| Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States RA Bright, DK Shay, B Shu, NJ Cox, AI Klimov Jama 295 (8), 891-894, 2006 | 924 | 2006 |
| Transmission of equine influenza virus to dogs PC Crawford, EJ Dubovi, WL Castleman, I Stephenson, EPJ Gibbs, ... science 310 (5747), 482-485, 2005 | 855 | 2005 |
| Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide VM Deyde, X Xu, RA Bright, M Shaw, CB Smith, Y Zhang, Y Shu, ... The Journal of infectious diseases 196 (2), 249-257, 2007 | 701 | 2007 |
| Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008 TG Sheu, VM Deyde, M Okomo-Adhiambo, RJ Garten, X Xu, RA Bright, ... Antimicrobial agents and chemotherapy 52 (9), 3284-3292, 2008 | 629 | 2008 |
| Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin RA Bright, DM Carter, S Daniluk, FR Toapanta, A Ahmad, V Gavrilov, ... Vaccine 25 (19), 3871-3878, 2007 | 360 | 2007 |
| C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge TM Ross, Y Xu, RA Bright, HL Robinson Nature immunology 1 (2), 127-131, 2000 | 310 | 2000 |
| Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle RA Bright, DM Carter, CJ Crevar, FR Toapanta, JD Steckbeck, KS Cole, ... PloS one 3 (1), e1501, 2008 | 284 | 2008 |
| Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice MA Hoelscher, S Garg, DS Bangari, JA Belser, X Lu, I Stephenson, ... The Lancet 367 (9509), 475-481, 2006 | 267 | 2006 |
| Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response TR Maines, KJ Szretter, L Perrone, JA Belser, RA Bright, H Zeng, ... Immunological reviews 225 (1), 68-84, 2008 | 234 | 2008 |
| Rapid scaling up of Covid-19 diagnostic testing in the United States—the NIH RADx initiative BJ Tromberg, TA Schwetz, EJ Pérez-Stable, RJ Hodes, RP Woychik, ... New England Journal of Medicine 383 (11), 1071-1077, 2020 | 232 | 2020 |
| Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012–2018 TG Buchman, SQ Simpson, KL Sciarretta, KP Finne, N Sowers, M Collier, ... Critical care medicine 48 (3), 276-288, 2020 | 210 | 2020 |
| H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses K Mahmood, RA Bright, N Mytle, DM Carter, CJ Crevar, JE Achenbach, ... Vaccine 26 (42), 5393-5399, 2008 | 166 | 2008 |
| Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice H Chen, RA Bright, K Subbarao, C Smith, NJ Cox, JM Katz, Y Matsuoka Virus research 128 (1-2), 159-163, 2007 | 166 | 2007 |
| Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza P Pushko, TM Tumpey, N Van Hoeven, JA Belser, R Robinson, M Nathan, ... Vaccine 25 (21), 4283-4290, 2007 | 141 | 2007 |
| High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season. RA Bright, D Shay, J Bresee, A Klimov, N Cox, J Ortiz MMWR: Morbidity & Mortality Weekly Report 55 (2), 2006 | 139 | 2006 |
| Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins JA Mitchell, TD Green, RA Bright, TM Ross Vaccine 21 (9-10), 902-914, 2003 | 132 | 2003 |
| A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets TM Ross, K Mahmood, CJ Crevar, K Schneider-Ohrum, PM Heaton, ... PloS one 4 (6), e6032, 2009 | 97 | 2009 |
| Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine RA Bright, TM Ross, K Subbarao, HL Robinson, JM Katz Virology 308 (2), 270-278, 2003 | 93 | 2003 |
| Influenza virus-like particles as pandemic vaccines SM Kang, P Pushko, RA Bright, G Smith, RW Compans Vaccines for pandemic influenza, 269-289, 2009 | 88 | 2009 |
